Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aussieguard natural products pty ltd - extract of lemon eucalyptus being acid modified oil of - aerosol - extract of lemon eucalyptus being acid modified oil of extract-plant active 338.0 g/kg - household insecticide - pest control - personal use - black fly | midges & sandflies - culicoides spp. | mosquito - aedes spp. | mosquito - anopheles spp. | mosquito - culex spp. | sand fly (biting midge) | stable fly | tick

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - methylphenidate hydrochloride - prolonged-release tablet - 18 milligram(s) - centrally acting sympathomimetics; methylphenidate - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit hyperactivity disorder in children aged 6 years and over

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

corteva agriscience australia pty ltd - aminopyralid present as hexyloxypropylamine salt; picloram present as the hexyloxypropylamine salt; triclopyr present as the butoxyethyl ester - emulsifiable concentrate - aminopyralid present as hexyloxypropylamine salt amino acid active 8.0 g/l; picloram present as the hexyloxypropylamine salt anilide/aniline-pyrimidine active 100.0 g/l; triclopyr present as the butoxyethyl ester pyridine-pyridinoxy active 300.0 g/l - herbicide - agricultural non-crop areas | commercial/industrial land | fallow land | forest | pasture | rights of way | commercial/industria - african boxthorn | angophora | australian or native blackthorn | banksia | bitter bark or quinine tree | blackberry in assoc with other weed (see | blackberry nightshade - suppression | blue heliotrope or blue top | camel or afghan melon | camphor laurel | cape or montpellier broom | capeweed | casuarina or sheoak | chilean cestrum | chinee apple | chinese scrub | cockspur thorn | common prickly pear | common sensitive plant | common sida | cowvine | crofton weed | cucumber melon | eastern cotton bush | english broom | eucalyptus | fireweed | flax leaf broom | furze or gorse | galenia | giant bramble | groundsel bush | hawthorn - less than 2 m tall | horehound | japanese sunflower | lantana - lantana camara | lantana - lantana montevidensis | limebush | lion tail | lucerne - established | manuka | mesquite | mesquite - prosopis velutina | milfoil or yarrow | mistflower or creeping crofton weed | mother-of-millions | paddy melon | parkinsonia | paterson's curse | polymeria | rubber vine - not infected with rus

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen-cilag ltd - methylphenidate hydrochloride; methylphenidate hydrochloride - prolonged-release tablet - 27 milligram(s) - centrally acting sympathomimetics; methylphenidate

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen-cilag ltd - methylphenidate hydrochloride; methylphenidate hydrochloride - prolonged-release tablet - 54 milligram(s) - centrally acting sympathomimetics; methylphenidate

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen-cilag ltd - methylphenidate hydrochloride - prolonged-release tablet - 36 milligram(s) - centrally acting sympathomimetics; methylphenidate

United States - English - NLM (National Library of Medicine)

lantheus medical imaging, inc. - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f-18 200 mci in 1 ml - fludeoxyglucose f 18 injection is indicated for positron emission tomography (pet) imaging in the following settings: for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. for the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. none risk summary data from published case series and case reports describe fludeoxyglucose f 18 injection crossing the placenta with uptake by the fetus (see data). all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose.

United States - English - NLM (National Library of Medicine)

houston cyclotron partners lp dba cyclotope - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 200 mci in 1 ml - pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fluoride f 18 injection or not to administer sodium fluoride f 18 injection, taking into account the importance of the drug to the mother. the body of scientific inform

United States - English - NLM (National Library of Medicine)

university of north dakota - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f-18 500 mci in 1 ml - fludeoxyglucose f 18 injection,usp is indicated in pet (positron emission tomography) for: 1. identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. 2. assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. 3. assessment of patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging, for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function. fludeoxyglucose f 18 injection, usp is not indicated for distinguishing epileptogenic foci from brain tumors or other brain lesions which may cause seizures. none known

United States - English - NLM (National Library of Medicine)

ucsf radiopharmaceutical facility - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 200 mci in 1 ml - sodium fluoride f 18 injection is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fl